Browsing by Author "Ahmad, Humayun"
Now showing items 1-10 of 10
-
Experience of romiplostin use in the management of ITP in a district general hospital setting-can fixed doses be used during stable phase to reduce wastage?
Van Staden, Bernhard; Ahmad, Humayun (2014-05)The thrombopoetin receptor agonist, Romiplostim is indicated in chronic ITP patients with refractory ITP. We reviewed and analysed the data from two refractory ITP patients managed with Romiplostim. Using current manufacturer ... -
Identifying patients with non-valvular atrial fibrillation & poorly controlled INR on warfarin who are suitable to be switched to NOACs
Ahmad, Humayun; Van Staden, Bernhard (2014-05)There are quite a significant number of patients of non valvular Atrial Fibrillation (AF) who are on Warfarin for stroke prevention but fail to achieve stable INR control and hence remain at risk. In recent years at least ... -
Late discovery of a case with TAR syndrome who presented with an additional potential bleeding risk other than thrombocytopenia
Van Staden, Bernhard; Ahmad, Humayun (2013-04)The name of this syndrome based on an acronym describing the so called 'most obvious' clinical features: Absent Radii & Thrombocytopenia (TAR). There may however be more to TAR cases than what the name says. Development ... -
Paper based system can achieve 100% traceability in transfusion-an audit report
Jeyachandran, Jeby; Li, Ellen; Buchan, Julie; Harlow, Glenys; Ahmad, Humayun (2014-10)The Blood Safety and Quality Regulations 2005 require 'unambiguous traceability' of all blood and blood components from a donor to patient, or the final destination of all blood and its components if not transfused. Achieving ... -
Successful creation of an electronic decision support tool to educate clinicians and develop a database to monitor the appropriate use of blood components at Burton Hospitals NHS foundation trust
Jeyachandran, Jeby; Buchan, Julie; Hopley, Alex; Ahmad, Humayun (2015-06)In the UK 2.9 million blood components are issued every year and only 4% of the eligible population give blood. When used safely and appropriately, blood transfusion saves and improves patient's lives however it is not ... -
Successful use of a charity to transport blood samples and blood components between a district general hospital and the national health service blood and transplant Birmingham
Jeyachandran, Jeby; Woodward, Karen; Ahmad, Humayun (2015-06)The transport of blood components are required to meet stringent standards as set out by the Blood Safety and Quality Regulations (BSQR) 2005 based on the 002/98/EC and 2004/33/EC European directive. In UK the blood ... -
Two case studies showing the importance of Coumarin tracing blood assays to investigate acquired coagulopathies in patients with selfharm behaviour
Ahmad, Humayun; Van Staden, Bernhard; Channa, Jawaid (2013-04)We have recent experience of two cases who presented with unexplained coagulopathies. Neither of them had a family or previous personal history of a bleeding tendency. They both denied the use of any medication. One case ... -
Understanding patterns of ordering common blood tests in patients admitted to hospital-an audit to evaluate number and frequency of common blood tests in admitted patients in a medium sized DGH
Ahmad, Humayun; Proud, Rebecca; Lennerova, Tereza; McDougall, Alexandra; Spence, Chloe (2013-06)Blood tests play a very important part in the diagnosis and management of most diseases and pathology costs form significant proportion of the health service budget. The Independent Review of Pathology Services in the ... -
Use of pre-recorded audio-visual information for patients diagnosed with six common haematological disorders with an aim to improve patient experience and facilitate breaking bad news
Ahmad, Humayun; Van Staden, Bernhard (2016-06) -
Varying ability of monoclonal anti-D reagents and weak RhD discrepancies-our experience
Jeyachandran, Jeby; Li, Ellen; Rady, Richard; Vintila, Oana; Ahmad, Humayun (2014-10)Rh is one of the important blood group system and D antigen is the most immunogenic and clinically significant because of the ability to cause haemolytic disease of new born and transfusion reactions. The monoclonal anti-D ...